When lung cancer is suspected and a piece of tissue is removed and sent for testing, the results take longer to come back than you might expect. In the eagerness to start treatment, a few days can feel like a month. But there is a clear reason for this wait. Lung cancers may look similar on the surface, yet on the inside their type and character vary widely, and which drug will work depends on what the tests show.
The first thing a biopsy reveals is the broad category of the cancer. Lung cancer divides mainly into non-small cell and small cell, and non-small cell further splits into adenocarcinoma, squamous cell carcinoma, and others. Looking at the shape of the cells under a microscope and deciding where they belong is the starting point. This distinction alone sets the broad framework of whether treatment heads toward surgery, chemotherapy, or radiation.
The next step deeper is genetic testing. From the same tissue, the lab checks whether specific genes such as EGFR, ALK, or ROS1 carry a mutation. If such a mutation is present, an oral targeted drug aimed precisely at it can be used, often working better than ordinary chemotherapy while placing less burden on the body. So if even one mutation turns up, the direction of treatment changes greatly. Because this is a test that looks for mutations, even a result where 'nothing shows up' has meaning, narrowing the next choice.
Another marker worth examining is PD-L1. This is closer to a gauge of how well the cancer cells evade your body's immune cells. The higher the PD-L1 expression, the greater the chance that immunotherapy will work well, which helps decide whether to use immunotherapy alone or alongside chemotherapy. This single figure, reported as a percentage, can change the treatment combination.
That all these tests do not come back at once is another reason the wait grows long. If there is not enough tissue, another sample may be needed, and genetic testing takes several more days to analyze in the machine. Frustrating as it is, rather than skipping this process and rushing to start, holding accurate information in hand and choosing the treatment most likely to work is far more advantageous in the long run.
While waiting for results, it helps to jot down your questions and ask them all together at the appointment. Once you know what type your lung cancer is, what mutations it carries, and what your PD-L1 level is, vague fear turns into a concrete plan. If you think of these tests not as buying time but as the most important preparation for raising the accuracy of treatment, your mind grows considerably lighter.
This article shares general medical information in plain language and does not replace individual diagnosis or treatment. Please discuss any specific decisions with your own care team.